Back to Research Home
UFPTUFP Technologies Inc
Health Care · Medical/Dental Instruments · Mid
$295.78−0.52%
As of 23 Oct 2026Mkt cap $2.3B
Stage 13
WAIT
Fundamentals
49.4/75
Technical
8.0/15
Independent
57.4/90
GCAE viewtechnical state requires waiting rather than entering now
Price
- 1M
- −0.9%
- 3M
- +19.0%
- 6M
- +47.8%
- 1Y
- +43.1%
Financials & valuation
Cached filing evidence · as of 2026-10-02
Valuation
- P/E
- 31.9xHist median 27.3x
- Forward P/E
- —No validated forward-estimate source
- Price / FCF
- 31.8x
- FCF yield
- 3.1%
Quality
- ROIC
- 14.0%
- Operating margin
- 15.3%
- FCF margin
- 11.3%
- Current ratio
- 2.7x
Growth
- Revenue growth
- +19.5%Latest FY YoY
- Revenue CAGR
- +30.7%
- EPS CAGR
- +43.0%
- FCF CAGR
- +85.6%
Capital
- Share-count trend
- +0.7%3Y annualised
- Net debt
- $134M1.5x OCF
Annual trend
- CAGR 2021–2025
- +30.7%
- Latest · 2025
- $1B
- YoY
- +19.5%
GCAE Research
- Quality Research
- PRE-AI
- Acceleration Radar
- FUNDAMENTAL GATE FAIL
- THE ONE
- NOT FLAGGED
- Final / Opportunity
- NOT FLAGGED
Key takeaway
technical state requires waiting rather than entering now
Unresolved question
No reliable unresolved question is available from the current committed evidence.
Watch next
- Next earnings · 2026-11-02
More details & evidence
Production decision
- Stage 13
- WAIT
- Technical state
- extended
- Rotation
- tailwind
- Evidence
- fresh
Presentation freshness
- Stage 11 market
- 2026-10-23 · Massive
- Financial cache
- 2026-10-02
- Quality Research
- CURRENT
- THE ONE
- NOT FLAGGED
Authority
- Company page
- Presentation only
- Scores
- Frozen GCAE production outputs
- Research
- Research-only lanes; no score override
- Private portfolio
- Not loaded